Department of Neurosurgery, Universitätsmedizin Berlin-Charité, Berlin, Germany.
Neurosurgery. 2010 Mar;66(3):465-74. doi: 10.1227/01.NEU.0000365272.77634.6B.
To evaluate the reliability of the gravitation-assisted adjustable proGAV shunt system with a prospective multicenter study conducted in 10 German hospitals.
Enrollment for this observational study began in April 2005 and concluded in February 2006. The protocol required re-examinations 3 and 6 months postoperatively and fixed the endpoint of follow-up at 12 months after implantation. Patients with different types of adult, juvenile, and pediatric hydrocephalus were included and 165 patients were enrolled; 9 died and 12 had incomplete follow-up.
Of the assessable 144 patients, 130 completed the protocol after 12 months, whereas 14 failed because of the need to explant the device, mainly because of infection. In 12 patients, components of the shunt, not the valve, were revised. In 65 of the 144 patients, there were 102 readjustments of the valve in 67 incidences because of underdrainage and in 35 because of overdrainage. In 1 case, readjustment was not possible. Determination of pressure level with the verification instrument was safe and corresponded to the required x-ray controls after adjustments. No unintended readjustments were noted.
The proGAV is a safe and reliable device.
通过在 10 家德国医院进行前瞻性多中心研究,评估 Gravitation-assisted Adjustable proGAV 分流系统的可靠性。
这项观察性研究于 2005 年 4 月开始招募患者,并于 2006 年 2 月结束。该方案要求术后 3 个月和 6 个月进行复查,并将随访的终点固定在植入后 12 个月。该研究纳入了不同类型的成人、青少年和儿童脑积水患者,共纳入 165 例患者,其中 9 例死亡,12 例失访。
可评估的 144 例患者中,130 例在 12 个月后完成了方案,14 例因需要取出装置而失败,主要是因为感染。在 14 例失败的患者中,有 12 例是分流器的部件而不是阀门需要更换。在 144 例患者中,有 12 例患者的 67 次中有 102 次因引流不足和 35 次因引流过度而需要调整阀门,65 例患者进行了阀门调整。在 1 例患者中,无法进行调整。使用验证仪器确定压力水平是安全的,并且与调整后的 X 射线检查相对应。未发现意外调整。
proGAV 是一种安全可靠的装置。